{"id":48575,"date":"2026-08-17T17:59:12","date_gmt":"2026-08-17T17:59:12","guid":{"rendered":"https:\/\/jornalboasnoticias.com.br\/home\/?p=48575"},"modified":"2026-08-17T17:59:12","modified_gmt":"2026-08-17T17:59:12","slug":"anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica","status":"publish","type":"post","link":"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/","title":{"rendered":"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica"},"content":{"rendered":"<blockquote>\n<p style=\"text-align: center;\">Subst\u00e2ncia se tornou conhecida como princ\u00edpio ativo do ozempic<\/p>\n<\/blockquote>\n<figure id=\"attachment_48497\" aria-describedby=\"caption-attachment-48497\" style=\"width: 1000px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-48497\" src=\"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2026\/08\/anvisa-e1786567122408.webp\" alt=\"\" width=\"1000\" height=\"598\" \/><figcaption id=\"caption-attachment-48497\" class=\"wp-caption-text\">\u00a9 Valter Campanato\/Ag\u00eancia Brasil<\/figcaption><\/figure>\n<p>A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou dois novos medicamentos injet\u00e1veis \u00e0\u00a0base de semaglutida obtida por via sint\u00e9tica.\u00a0Os registros foram publicados no Di\u00e1rio Oficial da Uni\u00e3o desta segunda (17).<img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.png?id=1699889&amp;o=node\" \/><img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.gif?id=1699889&amp;o=node\" \/><\/p>\n<p>A semaglutida ficou conhecida por ser o princ\u00edpio ativo das &#8220;canetas emagrecedoras&#8221; Ozempic e Wegovy, usadas no\u00a0tratamento para a diabetes mellitus tipo 2. M\u00e9dicos tamb\u00e9m receitam a subst\u00e2ncia para o controle da obesidade.<\/p>\n<p>Em maio, a farmac\u00eautica EMS obteve o primeiro registro de\u00a0semaglutida sint\u00e9tica no pa\u00eds, no medicamento Ozivy. Agora, a EMS foi autorizada a comercializar o gen\u00e9rico do Ozivy, que poder\u00e1 chegar ao mercado com pre\u00e7os mais baixos.\u00a0Como se trata de um rem\u00e9dio gen\u00e9rico, no entanto, a nova a caneta n\u00e3o pode ter um nome comercial.<\/p>\n<h2>Medicamento similar<\/h2>\n<p>A Anvisa\u00a0tamb\u00e9m aprovou medicamento similar \u00e0 base de semaglutida do laborat\u00f3rio Germed, vinculado \u00e0\u00a0EMS. Neste caso, al\u00e9m do princ\u00edpio ativo, a vers\u00e3o similar pode ter nome e caracteristicas pr\u00f3prias,\u00a0sem alterar o princ\u00edpio ativo, al\u00e9m de emblagem e rotulagem diferentes do rem\u00e9dio de refer\u00eancia. Este produto ser\u00e1 vendido como Semaclique.<\/p>\n<p>O registro\u00a0da ag\u00eancia reguladora reconhece\u00a0o uso dos medicamentos aliado \u00e0 dieta e aos exerc\u00edcios f\u00edsicos.\u00a0Eles s\u00e3o administrados semanalmente e devem ficar armazenados em geladeira (em temperaturas de 2 \u00b0C a 8 \u00b0C) antes e depois de iniciado o tratamento.<\/p>\n<p>A ag\u00eancia refor\u00e7a ainda a necessidade do acompanhamento m\u00e9dico para o uso das canetas de semaglutida: &#8220;Como todos os medicamentos do tipo GLP-1, a semaglutida sint\u00e9tica est\u00e1 sujeita \u00e0 prescri\u00e7\u00e3o de receita m\u00e9dica em duas vias&#8221;.<\/p>\n<h2>Apresenta\u00e7\u00f5es dos medicamentos aprovadas pela Anvisa<\/h2>\n<ul>\n<li>Solu\u00e7\u00e3o injet\u00e1vel de semaglutida 1,34 mg\/mL em sistema de aplica\u00e7\u00e3o preenchido (multidose e descart\u00e1vel) com 1,5 ml + 1 caneta + 6 agulhas;<\/li>\n<li>Solu\u00e7\u00e3o injet\u00e1vel de semaglutida 1,34 mg\/mL em sistema de aplica\u00e7\u00e3o preenchido (multidose e descart\u00e1vel) com 3 ml + 2 canetas +10 agulhas;<\/li>\n<li>Solu\u00e7\u00e3o injet\u00e1vel de semaglutida 1,34 mg\/mL em sistema de aplica\u00e7\u00e3o preenchido (multidose e descart\u00e1vel) com 1,5 ml + 1 caneta + 4 agulhas;<\/li>\n<li>Solu\u00e7\u00e3o injet\u00e1vel de semaglutida 1,34 mg\/mL em sistema de aplica\u00e7\u00e3o preenchido (multidose e descart\u00e1vel) com 3 ml + 2 canetas + 8 agulhas.<\/li>\n<\/ul>\n<p><em>Ag\u00eancia Brasil<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Subst\u00e2ncia se tornou conhecida como princ\u00edpio ativo do ozempic A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria<\/p>\n","protected":false},"author":3,"featured_media":48497,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-48575","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saude"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica - Jornal<\/title>\n<meta name=\"description\" content=\"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica - Jornal\" \/>\n<meta property=\"og:description\" content=\"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/\" \/>\n<meta property=\"og:site_name\" content=\"Jornal\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/boasnoticiasjornal\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-17T17:59:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2026\/08\/anvisa-e1786567122408.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"598\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Luiz Carlos da Cruz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luiz Carlos da Cruz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\\\/\"},\"author\":{\"name\":\"Luiz Carlos da Cruz\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#\\\/schema\\\/person\\\/75f9ebde398c998c166475fb446bda62\"},\"headline\":\"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica\",\"datePublished\":\"2026-08-17T17:59:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\\\/\"},\"wordCount\":415,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/anvisa-e1786567122408.webp\",\"articleSection\":[\"SA\u00daDE\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\\\/\",\"url\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\\\/\",\"name\":\"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica - Jornal\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/anvisa-e1786567122408.webp\",\"datePublished\":\"2026-08-17T17:59:12+00:00\",\"description\":\"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\\\/#primaryimage\",\"url\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/anvisa-e1786567122408.webp\",\"contentUrl\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/anvisa-e1786567122408.webp\",\"width\":1000,\"height\":598,\"caption\":\"\u00a9 Valter Campanato\\\/Ag\u00eancia Brasil\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#website\",\"url\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/\",\"name\":\"Jornal Boas Not\u00edcias\",\"description\":\"Boas not\u00edcias\",\"publisher\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#organization\",\"name\":\"Coq Editora Ltda\",\"alternateName\":\"Jornal Boas Noticias\",\"url\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-logo.jpg\",\"width\":290,\"height\":142,\"caption\":\"Coq Editora Ltda\"},\"image\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/boasnoticiasjornal\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#\\\/schema\\\/person\\\/75f9ebde398c998c166475fb446bda62\",\"name\":\"Luiz Carlos da Cruz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e6f4f45301b6cb8572f7b076572e8ac11c1db80e805d8c8d0858cf286ce3ac3b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e6f4f45301b6cb8572f7b076572e8ac11c1db80e805d8c8d0858cf286ce3ac3b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e6f4f45301b6cb8572f7b076572e8ac11c1db80e805d8c8d0858cf286ce3ac3b?s=96&d=mm&r=g\",\"caption\":\"Luiz Carlos da Cruz\"},\"url\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/author\\\/luiz-carlos-da-cruz\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica - Jornal","description":"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/","og_locale":"pt_BR","og_type":"article","og_title":"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica - Jornal","og_description":"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica","og_url":"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/","og_site_name":"Jornal","article_publisher":"https:\/\/www.facebook.com\/boasnoticiasjornal","article_published_time":"2026-08-17T17:59:12+00:00","og_image":[{"width":1000,"height":598,"url":"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2026\/08\/anvisa-e1786567122408.webp","type":"image\/webp"}],"author":"Luiz Carlos da Cruz","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Luiz Carlos da Cruz","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/#article","isPartOf":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/"},"author":{"name":"Luiz Carlos da Cruz","@id":"https:\/\/jornalboasnoticias.com.br\/home\/#\/schema\/person\/75f9ebde398c998c166475fb446bda62"},"headline":"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica","datePublished":"2026-08-17T17:59:12+00:00","mainEntityOfPage":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/"},"wordCount":415,"commentCount":0,"publisher":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/#organization"},"image":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/#primaryimage"},"thumbnailUrl":"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2026\/08\/anvisa-e1786567122408.webp","articleSection":["SA\u00daDE"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/","url":"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/","name":"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica - Jornal","isPartOf":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/#primaryimage"},"image":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/#primaryimage"},"thumbnailUrl":"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2026\/08\/anvisa-e1786567122408.webp","datePublished":"2026-08-17T17:59:12+00:00","description":"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica","breadcrumb":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/#primaryimage","url":"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2026\/08\/anvisa-e1786567122408.webp","contentUrl":"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2026\/08\/anvisa-e1786567122408.webp","width":1000,"height":598,"caption":"\u00a9 Valter Campanato\/Ag\u00eancia Brasil"},{"@type":"BreadcrumbList","@id":"https:\/\/jornalboasnoticias.com.br\/home\/anvisa-aprova-novas-canetas-de-semaglutida-incluindo-a-1a-generica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/jornalboasnoticias.com.br\/home\/"},{"@type":"ListItem","position":2,"name":"Anvisa aprova novas canetas de semaglutida, incluindo a 1\u00aa gen\u00e9rica"}]},{"@type":"WebSite","@id":"https:\/\/jornalboasnoticias.com.br\/home\/#website","url":"https:\/\/jornalboasnoticias.com.br\/home\/","name":"Jornal Boas Not\u00edcias","description":"Boas not\u00edcias","publisher":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jornalboasnoticias.com.br\/home\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/jornalboasnoticias.com.br\/home\/#organization","name":"Coq Editora Ltda","alternateName":"Jornal Boas Noticias","url":"https:\/\/jornalboasnoticias.com.br\/home\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/jornalboasnoticias.com.br\/home\/#\/schema\/logo\/image\/","url":"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2024\/07\/cropped-logo.jpg","contentUrl":"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2024\/07\/cropped-logo.jpg","width":290,"height":142,"caption":"Coq Editora Ltda"},"image":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/boasnoticiasjornal"]},{"@type":"Person","@id":"https:\/\/jornalboasnoticias.com.br\/home\/#\/schema\/person\/75f9ebde398c998c166475fb446bda62","name":"Luiz Carlos da Cruz","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/e6f4f45301b6cb8572f7b076572e8ac11c1db80e805d8c8d0858cf286ce3ac3b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e6f4f45301b6cb8572f7b076572e8ac11c1db80e805d8c8d0858cf286ce3ac3b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e6f4f45301b6cb8572f7b076572e8ac11c1db80e805d8c8d0858cf286ce3ac3b?s=96&d=mm&r=g","caption":"Luiz Carlos da Cruz"},"url":"https:\/\/jornalboasnoticias.com.br\/home\/author\/luiz-carlos-da-cruz\/"}]}},"_links":{"self":[{"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/posts\/48575","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/comments?post=48575"}],"version-history":[{"count":1,"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/posts\/48575\/revisions"}],"predecessor-version":[{"id":48576,"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/posts\/48575\/revisions\/48576"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/media\/48497"}],"wp:attachment":[{"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/media?parent=48575"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/categories?post=48575"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/tags?post=48575"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}